1. Home
  2. SCLXW vs LBRDP Comparison

SCLXW vs LBRDP Comparison

Compare SCLXW & LBRDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

N/A

Current Price

$0.20

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Logo Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock

LBRDP

Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock

HOLD

Current Price

$21.70

Market Cap

0.0

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLXW
LBRDP
Founded
N/A
N/A
Country
United States
United States
Employees
34
1900
Industry
Biotechnology: Pharmaceutical Preparations
Cable & Other Pay Television Services
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLXW
LBRDP
Price
$0.20
$21.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.9K
11.3K
Earning Date
03-07-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$55,152,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.02
N/A
52 Week Low
$0.05
$21.05
52 Week High
$0.64
$25.55

Technical Indicators

Market Signals
Indicator
SCLXW
LBRDP
Relative Strength Index (RSI) 57.69 50.91
Support Level $0.11 $21.32
Resistance Level $0.21 $22.29
Average True Range (ATR) 0.02 0.35
MACD 0.01 0.02
Stochastic Oscillator 92.12 62.35

Price Performance

Historical Comparison
SCLXW
LBRDP

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About LBRDP Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services, including video, internet, voice, and mobile services; commercial services, including small and medium business and enterprise solutions; advertising services; and other services. The company's reportable segments are GCI Holdings and Charter. The firm derives the majority of its revenue from GCI Holdings.

Share on Social Networks: